OBJECTIVE: To examine the association between cardiorespiratory fitness (CRF) and risk of incident prostate cancer (PrCA). METHODS: Participants were 19,042 male subjects in the Aerobics Center Longitudinal Study (ACLS), ages 20-82years, who received a baseline medical examination including a maximal treadmill exercise test between 1976 and 2003. CRF levels were defined as low (lowest 20%), moderate (middle 40%), and high (upper 40%) according to age-specific distribution of treadmill duration from the overall ACLS population. PrCA was assessed from responses to mail-back health surveys during 1982-2004. Cox proportional hazards regression models, adjusted for potential confounders, were used to compute hazard ratios (HRs), 95% confidence intervals (95% CIs), and incidence rates (per 10,000 person-years of follow-up). RESULTS: A total of 634 men reported a diagnosis of incident PrCA during an average of 9.3 ± 7.1 years of follow-up. Adjusted HRs (95% CIs) in men with moderate and high CRF relative to low CRF were, 1.68 (1.13-2.48) and 1.74 (1.15-2.62), respectively. The positive association between CRF and PrCA was observed only in the strata of men who were not obese, had ≥ 1 follow-up examination, or who were diagnosed ≤ 1995. CONCLUSIONS: Rather than revealing a causal relationship, the unexpected positive association observed between CRF and incident PrCA is most likely due to a screening/detection bias in more fit men who also are more health-conscious. Results have important implications for understanding the health-related factors that predispose men to receive PrCA screening that may lead to over-detection of indolent disease. Published by Elsevier Ltd.
OBJECTIVE: To examine the association between cardiorespiratory fitness (CRF) and risk of incident prostate cancer (PrCA). METHODS:Participants were 19,042 male subjects in the Aerobics Center Longitudinal Study (ACLS), ages 20-82years, who received a baseline medical examination including a maximal treadmill exercise test between 1976 and 2003. CRF levels were defined as low (lowest 20%), moderate (middle 40%), and high (upper 40%) according to age-specific distribution of treadmill duration from the overall ACLS population. PrCA was assessed from responses to mail-back health surveys during 1982-2004. Cox proportional hazards regression models, adjusted for potential confounders, were used to compute hazard ratios (HRs), 95% confidence intervals (95% CIs), and incidence rates (per 10,000 person-years of follow-up). RESULTS: A total of 634 men reported a diagnosis of incident PrCA during an average of 9.3 ± 7.1 years of follow-up. Adjusted HRs (95% CIs) in men with moderate and high CRF relative to low CRF were, 1.68 (1.13-2.48) and 1.74 (1.15-2.62), respectively. The positive association between CRF and PrCA was observed only in the strata of men who were not obese, had ≥ 1 follow-up examination, or who were diagnosed ≤ 1995. CONCLUSIONS: Rather than revealing a causal relationship, the unexpected positive association observed between CRF and incident PrCA is most likely due to a screening/detection bias in more fit men who also are more health-conscious. Results have important implications for understanding the health-related factors that predispose men to receive PrCA screening that may lead to over-detection of indolent disease. Published by Elsevier Ltd.
Authors: J R Cerhan; J C Torner; C F Lynch; L M Rubenstein; J H Lemke; M B Cohen; D M Lubaroff; R B Wallace Journal: Cancer Causes Control Date: 1997-03 Impact factor: 2.506
Authors: E M Simonsick; M E Lafferty; C L Phillips; C F Mendes de Leon; S V Kasl; T E Seeman; G Fillenbaum; P Hebert; J H Lemke Journal: Am J Public Health Date: 1993-10 Impact factor: 9.308
Authors: James R Hébert; Thomas G Hurley; Brook E Harmon; Sue Heiney; Christine J Hebert; Susan E Steck Journal: Cancer Epidemiol Date: 2011-10-20 Impact factor: 2.984
Authors: Rajagopalan Sridhar; Vernon Bond; Jacquelyn Dunmore-Griffith; Valerie M Cousins; Renshu Zhang; Richard M Millis Journal: Am J Mens Health Date: 2016-06-22
Authors: Susan G Lakoski; Benjamin L Willis; Carolyn E Barlow; David Leonard; Ang Gao; Nina B Radford; Stephen W Farrell; Pamela S Douglas; Jarett D Berry; Laura F DeFina; Lee W Jones Journal: JAMA Oncol Date: 2015-05 Impact factor: 31.777
Authors: Tisha M Felder; Heather M Brandt; Cheryl A Armstead; Philip P Cavicchia; Kathryn L Braun; Swann A Adams; Daniela B Friedman; Sora Tanjasiri; Susan E Steck; Emily R Smith; Virginie G Daguisé; James R Hébert Journal: J Cancer Educ Date: 2012-06 Impact factor: 2.037
Authors: Fred Tabung; Susan E Steck; L Joseph Su; James L Mohler; Elizabeth T H Fontham; Jeannette T Bensen; James R Hebert; Hongmei Zhang; Lenore Arab Journal: Prostate Cancer Date: 2012-11-13
Authors: Trude E Robsahm; Ragnhild S Falk; Trond Heir; Leiv Sandvik; Linda Vos; Jan E Erikssen; Steinar Tretli Journal: Cancer Med Date: 2016-05-26 Impact factor: 4.452